Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

77 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Biomarker-driven therapies for previously treated squamous non-small-cell lung cancer (Lung-MAP SWOG S1400): a biomarker-driven master protocol.
Redman MW, Papadimitrakopoulou VA, Minichiello K, Hirsch FR, Mack PC, Schwartz LH, Vokes E, Ramalingam S, Leighl N, Bradley J, Miao J, Moon J, Highleyman L, Miwa C, LeBlanc ML, Malik S, Miller VA, Sigal EV, Adam S, Wholley D, Sigman C, Smolich B, Blanke CD, Kelly K, Gandara DR, Herbst RS. Redman MW, et al. Among authors: sigal ev. Lancet Oncol. 2020 Dec;21(12):1589-1601. doi: 10.1016/S1470-2045(20)30475-7. Epub 2020 Oct 27. Lancet Oncol. 2020. PMID: 33125909 Free PMC article. Clinical Trial.
Lung Master Protocol (Lung-MAP)-A Biomarker-Driven Protocol for Accelerating Development of Therapies for Squamous Cell Lung Cancer: SWOG S1400.
Herbst RS, Gandara DR, Hirsch FR, Redman MW, LeBlanc M, Mack PC, Schwartz LH, Vokes E, Ramalingam SS, Bradley JD, Sparks D, Zhou Y, Miwa C, Miller VA, Yelensky R, Li Y, Allen JD, Sigal EV, Wholley D, Sigman CC, Blumenthal GM, Malik S, Kelloff GJ, Abrams JS, Blanke CD, Papadimitrakopoulou VA. Herbst RS, et al. Among authors: sigal ev. Clin Cancer Res. 2015 Apr 1;21(7):1514-24. doi: 10.1158/1078-0432.CCR-13-3473. Epub 2015 Feb 13. Clin Cancer Res. 2015. PMID: 25680375 Free PMC article. Clinical Trial.
New drug approvals in oncology.
Kurzrock R, Kantarjian HM, Kesselheim AS, Sigal EV. Kurzrock R, et al. Among authors: sigal ev. Nat Rev Clin Oncol. 2020 Mar;17(3):140-146. doi: 10.1038/s41571-019-0313-2. Epub 2020 Feb 4. Nat Rev Clin Oncol. 2020. PMID: 32020042 Review.
Regulatory decision-making meets the real world.
Hohman R, Shea M, Kozak M, Roberts S, Allen J, Sigal E. Hohman R, et al. Sci Transl Med. 2015 Nov 11;7(313):313fs46. doi: 10.1126/scitranslmed.aad5233. Sci Transl Med. 2015. PMID: 26560355
Achieving the goals of effective, safe, and individualized cancer care.
Roberts SA, Karnes EK, Allen JD, Benner JS, Sigal EV, McClellan M. Roberts SA, et al. Among authors: sigal ev. Clin Cancer Res. 2011 Nov 1;17(21):6632-3. doi: 10.1158/1078-0432.CCR-11-1104. Clin Cancer Res. 2011. PMID: 22046023 No abstract available.
The Value of Addressing Patient Preferences.
Allen JD, Stewart MD, Roberts SA, Sigal EV. Allen JD, et al. Among authors: sigal ev. Value Health. 2017 Feb;20(2):283-285. doi: 10.1016/j.jval.2016.11.029. Value Health. 2017. PMID: 28237210 Free article.
Developing standards for breakthrough therapy designation in oncology.
Horning SJ, Haber DA, Selig WK, Ivy SP, Roberts SA, Allen JD, Sigal EV, Sawyers CL. Horning SJ, et al. Among authors: sigal ev. Clin Cancer Res. 2013 Aug 15;19(16):4297-304. doi: 10.1158/1078-0432.CCR-13-0523. Epub 2013 May 29. Clin Cancer Res. 2013. PMID: 23719260 Free PMC article.
77 results